[English] 日本語
Yorodumi- EMDB-76694: Cryo-EM structure of SARS-CoV-2 BA.3.2.1 spike with K852A mutatio... -
+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | Cryo-EM structure of SARS-CoV-2 BA.3.2.1 spike with K852A mutation, flexible conformation | |||||||||
Map data | ||||||||||
Sample |
| |||||||||
Keywords | SARS-CoV-2 / VIRAL PROTEIN | |||||||||
| Biological species | ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 2.73 Å | |||||||||
Authors | Wang Y / Hu Y / Xie X | |||||||||
| Funding support | 1 items
| |||||||||
Citation | Journal: Cell Rep / Year: 2026Title: Functional and structural basis of Omicron BA.3.2.1 spike. Authors: Yan Wang / Yanping Hu / Zhenhang Chen / Jing Zou / Ke Zhang / Ping Ren / Pei-Yong Shi / Bo Liang / Xuping Xie / ![]() Abstract: SARS-CoV-2 BA.3.2 sublineages, derived from BA.3 and carrying substantial spike divergence, raised concerns about altered fitness and antigenicity. Using BA.3.2.1 as a representative strain, we ...SARS-CoV-2 BA.3.2 sublineages, derived from BA.3 and carrying substantial spike divergence, raised concerns about altered fitness and antigenicity. Using BA.3.2.1 as a representative strain, we engineered live-attenuated SARS-CoV-2 encoding BA.3.2.1, LP.8.1, or XEC spikes and benchmarked them against BA.3 and KP.3. BA.3.2.1 outcompetes BA.3 in primary human airway epithelium but replicates less efficiently than JN.1 descendants and shows the greatest resistance to neutralization by KP.2/KP.3 convalescent sera. Although BA.3.2.1 RBD binds hACE2 with high affinity, its trimeric spike engages hACE2 less efficiently than LP.8.1. Cryoelectron microscopy structures reveal that BA.3.2.1 spike predominantly adopts a compact, asymmetric closed conformation stabilized by protomer rearrangements, N-linked glycosylation, and a distinct fusion-peptide-proximal region. This architecture increases spike stability, limits receptor engagement, reduces fusogenicity, and masks antibody-sensitive epitopes. Thus, BA.3.2.1 enhances immune evasion at the cost of replication fitness, providing a structural-functional explanation for BA.3.2's limited prevalence and underscoring the need for continued variant surveillance. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_76694.map.gz | 137 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-76694-v30.xml emd-76694.xml | 16.4 KB 16.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_76694_fsc.xml | 13.7 KB | Display | FSC data file |
| Images | emd_76694.png | 69.7 KB | ||
| Filedesc metadata | emd-76694.cif.gz | 5.6 KB | ||
| Others | emd_76694_half_map_1.map.gz emd_76694_half_map_2.map.gz | 254.7 MB 254.7 MB | ||
| Archive directory | https://data.pdbj.org/pub/emdb/structures/EMD-76694 ftp://data.pdbj.org/pub/emdb/structures/EMD-76694 | HTTPS FTP |
-Related structure data
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_76694.map.gz / Format: CCP4 / Size: 274.6 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.832 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: #1
| File | emd_76694_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: #2
| File | emd_76694_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : SARS-CoV-2 BA.3.2.1 spike with K852A mutation
| Entire | Name: SARS-CoV-2 BA.3.2.1 spike with K852A mutation |
|---|---|
| Components |
|
-Supramolecule #1: SARS-CoV-2 BA.3.2.1 spike with K852A mutation
| Supramolecule | Name: SARS-CoV-2 BA.3.2.1 spike with K852A mutation / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: SARS-CoV-2 BA.3.2.1 spike with K852A mutation
| Macromolecule | Name: SARS-CoV-2 BA.3.2.1 spike with K852A mutation / type: protein_or_peptide / ID: 1 / Enantiomer: DEXTRO |
|---|---|
| Source (natural) | Organism: ![]() |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: MFVFLVLLLL VSSQCVNLTT TTQLPLAYTN SFTRGVYYPD KVFRSSVLHS TQDLFLPFFS NVTWFHVISG TNGTKRFDNP VLPFNDGVYF ASIEKSNITR GWIFGTTLDS KTQSLLIVNN ATNVVIKVCE FQFNNKSWME SESRVYSSAK NCTFEYVFQP FLMDLEGKQG ...String: MFVFLVLLLL VSSQCVNLTT TTQLPLAYTN SFTRGVYYPD KVFRSSVLHS TQDLFLPFFS NVTWFHVISG TNGTKRFDNP VLPFNDGVYF ASIEKSNITR GWIFGTTLDS KTQSLLIVNN ATNVVIKVCE FQFNNKSWME SESRVYSSAK NCTFEYVFQP FLMDLEGKQG NFTNLREFVF KNIDGYFKIY SKHTPIIVRD LPQGFSALEP LVDLPIGINI TRFQTLLHRS YLTSGDSSSG WTAGAAAYYV GYLQPRTFLL KYNENGTITD AVDCALDPLS ETKCTLKSFT VEKGIYQTSN FRVQPTESVV RFPNITNLCP FYEVFNATRF PSVYAWNRKR ISNCVADYSV LYNFAPFFTF KCYGVSPTKL NDLCFTNVYA DSFVIKGNEV SQIAPGQTGN IADYNYKLPD DFTGCVISWN SNRLDSKADG NYNYWYRLFR KSKLKPFERD ISTEIYQAGN NPCNGVKGFN CYFPLQSYSF RPTYGVGYQP YRVVVLSFEL LHAPATVCGP KNSTNLVKNK CVNFNFNGLT GTGVLTDSNK KFLPFQQFGR DIADTTDAVR DPQTLDILDI TPCSFGGVSV ITPGTNTSNQ VAVLYQGVNC TEVPVAIRAD QLTPTWRVYS TGSKGFQTRA GCLIGAKYVN NSYECDIPIG AGICASYQTQ TRSRGSASSV DSQSIIAYTM SLGAENLVAY SNNSIAIPTN FTISVTTEIL PVSMTKTSVD CTMYICGDST ECSNLLLQYG SFCTQLKRAL TGIAVEQDKN TQEVFAQVKQ IYKTPPITYF GGFNFSQILP DPSKPSKRSP IEDLLFNKVT LADAGFIKQY GDCLGDIAAR DLICAQKFNG LTVLPPLLTD EMIAQYTSAL LAGTITSGWT FGAGPALQIP FPMQMAYRFN GIGVTQNVLY ENQKLIANQF NSAIGKIQDS LFSTPSALGK LQDVVNHNAQ ALNTLVKQLS SKFGAISSVL NDILSRLDPP EAEVQIDRLI TGRLQSLQTY VTQQLIRAAE IRASANLAAT KMSECVLGQS KRVDFCGKGY HLMSFPQSAP HGVVFLHVTY VPAQEKNFTT APAICHDGKA HFPREGVFVS NGTHWFVTQR NFYEPQIITT DNTFVSGNCD VVIGIVNNTV YDPLQPELDS FKEELDKYFK NHTSRDVDLG DISGINASVV NIQKEIERLN EVAKNLNESL IDLQELGKYE QGSGYIPEAP RDGQAYVRKD GEWVLLSTFL GRSLEVLFQG PGHHHHHHHH SAWSHPQFEK GGGSGGGGSG GSAWSHPQFE K |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 1.0 mg/mL | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Buffer | pH: 8 Component:
| |||||||||
| Grid | Model: Quantifoil R1.2/1.3 / Material: COPPER / Mesh: 300 / Pretreatment - Type: GLOW DISCHARGE | |||||||||
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 281 K |
-
Electron microscopy
| Microscope | TFS KRIOS |
|---|---|
| Image recording | Film or detector model: GATAN K3 (6k x 4k) / Average electron dose: 41.0 e/Å2 |
| Electron beam | Acceleration voltage: 300 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: DIFFRACTION / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.5 µm |
| Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |
Movie
Controller
About Yorodumi



Keywords
Authors
Citation











Z (Sec.)
Y (Row.)
X (Col.)




































Homo sapiens (human)
Processing
FIELD EMISSION GUN

